• ქართული
  • English
  • GSK pulls out of $20 billion race for Pfizer consumer assets

    LONDON (Reuters) – GlaxoSmithKline has withdrawn from the race to buy Pfizer’s consumer healthcare business, the British company said on Friday, endangering an auction the U.S. drugmaker hoped would bring in as much as $20 billion.

    Market Quotes by TradingView